Allena Pharmaceuticals Reports Inducement Grants Under

Allena Pharmaceuticals Reports Inducement Grants Under

News Highlights

NEWTON, Mass., May 04, 2021 (News) — Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced the granting of an inducement award to a new employee. In accordance with NASDAQ Listing Rule 5635(c)(4), the award was approved by Allena’s Compensation Committee and made as a material inducement to the employee’s entry into employment with the Company.

In connection with the commencement of their employment, the employee received stock options on May 3, 2021 to purchase an aggregate 55,000 shares of Allena common stock. The stock options were granted pursuant to Allena’s 2021 Inducement Plan and have an exercise price of $1.28 per share, the closing trading price on the Nasdaq Global Select Market on the date of grant. The stock options vest over four years, with 25% vesting on the one-year anniversary of each employee’s first day of employment with the Company and 1/36 of the remaining shares vesting monthly thereafter, subject to each new employee’s continued service relationship with the Company on each such date. The stock options have a 10-year term and are subject to terms and conditions of the Company’s 2021 Inducement Plan and a stock option agreement covering the grant.

About Allena Pharmaceuticals

Allena Pharmaceuticals, Inc. is a late-stage biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class, oral biologic therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena’s lead product candidate, reloxaliase, is currently being evaluated in a pivotal Phase 3 clinical program for the treatment of enteric hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders. Allena is also developing ALLN-346 for the treatment of hyperuricemia in the setting of gout and advanced chronic kidney disease, with a Phase 1 multiple-ascending dose study and a Phase 2a program planned for 2021.

Investor ContactHannah DeresiewiczStern Investor Relations, Inc.212-362-1200hannah.deresiewicz@sternir.com

Media ContactAdam DaleyBerry & Company Public Relations212-253-8881adaley@berrypr.com

  • Check the latest Health news updates and information.
  • Please share this news Allena Pharmaceuticals Reports Inducement Grants Under with your friends and family to support us your one share helps us a lot.
Disclaimer: If you need to edit or update this news from compsmag then kindly contact us Learn more

For Latest News Follow us on Google News


Latest Headlines
  • Show all
  • Trending News
  • Popular By week
The Best Relaxing Games on PS5

The Best Relaxing Games on PS5

Thankfully, there are plenty of relaxing games on PS5, thanks to the console’s ability to play most PS4 games. So whether you’re looking for a puzzle game to ...
To Invest in Biometric Security Tech iiDENTIFii motivates South African Businesses 

To Invest in Biometric Security Tech iiDENTIFii motivates South African Businesses 

iiDENTIFii is arguing that South Africa should invest in biometric security technologies to kickstart the economy after the pandemic. In that regard, the ...
Productivity recovers with a solid rate of 5.4% in the first quarter – Finance and Trade

Productivity recovers with a solid rate of 5.4% in the first quarter – Finance and Trade

For all of 2020, productivity rose 2.5%, a slight improvement from a 1.8% gain in 2019. Productivity lagged throughout the record-long economic expansion which ...
“Zero Trust Should act as Foundation for All Security Methods”

“Zero Trust Should act as Foundation for All Security Methods”

Although zero trust has become a bit of a buzzword in the IT world, experts agree that zero trust is “foundational” to all security approaches and that ...
Baptist Health will host final one-dose vaccine clinic

Baptist Health will host final one-dose vaccine clinic

Source Want to see how many vaccines have been administered in your county? Check out our exclusive COVID-19 Tracker.Are you fully vaccinated? Click here for ...
Mills is the true pro-business governor

Mills is the true pro-business governor

Please check your email to confirm and complete your registration. Invalid username/password. Use the form below to reset your password. When you’ve submitted ...
Coronavirus health metrics continue positive trends across the state

Coronavirus health metrics continue positive trends across the state

To qualify as high risk for coronavirus transmission, the DPH states communities with populations under 10,000 must have more than 25 cases of the virus. For ...
How can Remote learning increase Security threats

Oculus Quest 2 Air Link allows PC VR games to be wirelessly streamed to headsets

While it can be used on its own, the Oculus Quest 2 can also be connected to a PC to enjoy the already existing catalog of VR games and apps developed for ...
Nasdaq Approves Bitfarms Application to List

Nasdaq Approves Bitfarms Application to List

News Highlights ...
Show next
Compsmag - Latest News from tech, business and health
Logo